Prostaglandin E2 receptors in abdominal aortic aneurysm and human aortic smooth muscle cells

Journal of Vascular Surgery

Volumn 38, Issue 2, 2003, Pages 354-359

  Bayston, T ^a,b   Ramessur, S ^a,b   Reise, J ^a,b   Jones, K G ^a,b   Powell, J T ^a,b,c  

^a Imperial College ^*

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11 DEOXYPROSTAGLANDIN E1; BUTAPROST; CYCLIC AMP; INDOMETACIN; INTERLEUKIN 6; MESSENGER RNA; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; SULPROSTONE; EP4 RECEPTOR; PROSTAGLANDIN RECEPTOR;

ABDOMINAL AORTA ANEURYSM; AORTA MEDIA; ARTICLE; BLOOD VESSEL BIOPSY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; AORTA; APOPTOSIS; CELL CULTURE; CULTURE TECHNIQUE; CYTOLOGY; METABOLISM; PHYSIOLOGY; SECRETION;

AORTA; AORTIC ANEURYSM, ABDOMINAL; APOPTOSIS; CELLS, CULTURED; CULTURE TECHNIQUES; DINOPROSTONE; HUMANS; INTERLEUKIN-6; MACROPHAGES; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E;

EID: 0041884950     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)00339-2     Document Type: Article

References (26)

1. Dorn GW, Becker MW, Davis MG. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J Biol Chem 1992;267:24897-905.
2. Davies P, Bailey PJ, Goldenberg MM, Ford-Hutchinson AW. The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol 1984;2:335-57.
3. Corcoran ML, Stetler-Stevenson WG, Brown PD, Wahl LM. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type TV collagenase/gelatinase production by human monocytes. J Biol Chem 1992;267:515-9.
4. Holmes DR, Wester W, Thompson RW, Reilly JM. Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms. J Vasc Surg 1997;25:810-5.
5. Walton LJ, Franklin IJ, Bayston T, Brown LC, Greenhalgh RM, Taylor GW, et al. Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms. Circulation 1999;100:48-54.
6. Reilly JM, Miralles M, Wester WN, Sicard GA. Differential expression of prostaglandin E2 and interleukin-6 occlusive and aneurysmal aortic disease. Surgery 1999;126:624-7.
7. Miralles M, Wester W, Sicard GA, Thompson R, Reilly JM. Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase. J Vasc Surg 1999;29:884-92.
8. Coleman RA, Smith WL, Narumiya S. Classification of prostanoid receptors: properties, distribution and structure of the receptors and their subtypes. Pharmacol Rev 1994;46:205-29.
9. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties and functions. Physiol Rev 1999;79:1193-1226.
10. Paul BZS, Asby B, Sheth SB. Distribution of prostaglandin IP and EP receptor subtypes and isoforms in platelets and human umbilical artery smooth muscle cells. Br J Haematol 1998;102:1204-11.
11. Kotani M, Tanaka I, Ogawa Y, Usui T, Mori K, Ichikawa A, et al. Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EPS subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions. Mol Pharmacol 1995;48:869-79.
12. Indolfi C, Avvedimento EV, Di Lorenzo E, et al. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nature Med 1997;3:775-9.
13. Lopez-Caudales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 1997;150:993-1007.
14. Henderson EL, Geng Y-J, Sukhova GK, Whittemore AD, Knox J, Libby P. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 1999;99:96-104.
15. Zeng L, An S, Goetzl EJ. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EPS subtype of prostaglandin E2 receptor. J Biol Chem 1996;271: 27744-50.
16. Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries SE, et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001;103:2260-5.
17. Miralles M, Wester W, Sicard GA, Thompson R, Reilly JM. Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the Cox2 isoform of cyclooxygenase. J Vasc Surg 1999;29:884-92.
18. Franklin IJ, Walton LJ, Greenhalgh RM, Powell JT. The influence of indomethacin on the metabolism and cytokine secretion of human aneurysmal aorta. Eur J Vasc Endovasc Surg 1999;18:35-42.
19. Shah PK. Inflammation, metalloproteinases and increased proteolysis: an emerging pathological paradigm in aortic aneurysm. Circulation 1997;96:2115-7.
20. Liu F, Aubin JE, Malaval L. Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokinase and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF. Bone 2002;31:212-9.
21. De Haij S, Woltman AM, Bakker AC, Daha MR, Van Kooten C. Production of inflammatory mediators by renal epithelial cells is insensitive to glucocorticoids. Br J Pharmacol 2002;137:197-204.
22. Fiebich BL, Schleicher S, Spleiss O, Czygan M, Hull M. Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J Neurochem 2001;79:950-8.
23. Zeng L, An S, Goetzl EJ. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells. J Pharmacol Exp Ther 1998;286:1420-6.
24. Smith GC, Wu WX, Nijland MJ, Koenen SV, Nathanielsz PW. Effect of gestational age, corticosteroids, and birth on expression of prostanoid EP receptor genes in lamb and baboon ductus arteriosus. J Cardiovasc Pharmacol 2001;37:697-704.
25. Faour WH, He Y, He QW, de Ladurantaye M, Quintero M, Mancini A, et al. Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin treated human synodal fibroblasts. J Biol Chem 2001;276:31720-31.
26. McCoy JM, Wicks JR, Audoly LP. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 2002;110:651-8.